BRILACIDIN
UNII I1679X069H

Substance Identification & Data

This profile provides standardized clinical and technical data for Brilacidin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) I1679X069H.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1224095-98-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

I1679X069H

CAS Registry Number

1224095-98-0

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

BRILACIDIN

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C40H50F6N14O6

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

QPDYBCZNGUJZDK-DNQXCXABSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C169816

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

25023695

Unique identification number in the NCBI database of chemical substances.

INN ID

9693

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

ZZ-16

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

n1c(cc(nc1)C(=O)Nc2c(O[C@@H]3CCNC3)c(cc(c2)C(F)(F)F)NC(=O)CCCCNC(=N)N)C(Nc4c(c(NC(CCCCNC(N)=N)=O)cc(c4)C(F)(F)F)O[C@@H]5CCNC5)=O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Brilacidin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.